Annual Cash & Cash Equivalents
$4.91 M
+$3.37 M+219.80%
01 June 2024
Summary:
Kintara Therapeutics annual cash & cash equivalents is currently $4.91 million, with the most recent change of +$3.37 million (+219.80%) on 01 June 2024. During the last 3 years, it has fallen by -$5.63 million (-53.41%).KTRA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.91 M
-$1.44 M-22.71%
01 June 2024
Summary:
Kintara Therapeutics quarterly cash and cash equivalents is currently $4.91 million, with the most recent change of -$1.44 million (-22.71%) on 01 June 2024. Over the past year, it has increased by +$4.69 million (+2172.69%).KTRA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KTRA Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +219.8% | +2172.7% |
| 3 y3 years | -53.4% | -74.6% |
| 5 y5 years | +32.0% | -39.1% |
KTRA Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -58.3% | -78.3% |
Kintara Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | $4.91 M(+219.8%) | $4.91 M(-22.7%) |
| Mar 2024 | - | $6.35 M(+865.2%) |
| Dec 2023 | - | $658.00 K(+204.6%) |
| Sept 2023 | - | $216.00 K(-85.9%) |
| June 2023 | $1.53 M(-87.0%) | $1.53 M(-49.6%) |
| Mar 2023 | - | $3.04 M(-37.5%) |
| Dec 2022 | - | $4.87 M(-31.2%) |
| Sept 2022 | - | $7.08 M(-39.9%) |
| June 2022 | $11.78 M(+11.8%) | $11.78 M(+33.3%) |
| Mar 2022 | - | $8.84 M(-37.2%) |
| Dec 2021 | - | $14.06 M(-27.3%) |
| Sept 2021 | - | $19.34 M(+83.5%) |
| June 2021 | $10.54 M(+340.5%) | $10.54 M(-33.0%) |
| Mar 2021 | - | $15.72 M(-8.4%) |
| Dec 2020 | - | $17.16 M(-24.1%) |
| Sept 2020 | - | $22.60 M(+844.9%) |
| June 2020 | $2.39 M(-35.7%) | $2.39 M(-51.9%) |
| Mar 2020 | - | $4.97 M(-21.7%) |
| Dec 2019 | - | $6.35 M(-21.2%) |
| Sept 2019 | - | $8.06 M(+116.7%) |
| June 2019 | $3.72 M(-37.7%) | $3.72 M(+72.8%) |
| Mar 2019 | - | $2.15 M(-41.9%) |
| Dec 2018 | - | $3.70 M(-4.7%) |
| Sept 2018 | - | $3.88 M(-34.9%) |
| June 2018 | $5.97 M(-9.3%) | $5.97 M(-29.8%) |
| Mar 2018 | - | $8.51 M(-22.8%) |
| Dec 2017 | - | $11.02 M(-16.2%) |
| Sept 2017 | - | $13.16 M(+99.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | $6.59 M(+7.0%) | $6.59 M(+213.6%) |
| Mar 2017 | - | $2.10 M(-38.5%) |
| Dec 2016 | - | $3.42 M(-28.8%) |
| Sept 2016 | - | $4.80 M(-22.1%) |
| June 2016 | $6.16 M(+251.0%) | $6.16 M(+556.8%) |
| Mar 2016 | - | $937.40 K(-52.1%) |
| Dec 2015 | - | $1.96 M(-30.2%) |
| Sept 2015 | - | $2.80 M(+59.8%) |
| June 2015 | $1.75 M(-63.1%) | $1.75 M(-41.6%) |
| Mar 2015 | - | $3.01 M(-24.0%) |
| Dec 2014 | - | $3.96 M(-8.3%) |
| Sept 2014 | - | $4.32 M(+24.2%) |
| June 2014 | $4.76 M(+15.1%) | - |
| Mar 2014 | - | $3.47 M(-16.0%) |
| Dec 2013 | $4.14 M(>+9900.0%) | $4.14 M(-20.0%) |
| Sept 2013 | - | $5.17 M(-17.7%) |
| June 2013 | - | $6.28 M(-16.6%) |
| Mar 2013 | - | $7.53 M(>+9900.0%) |
| Dec 2012 | - | $4000.00(+566.7%) |
| Sept 2012 | - | $600.00(-66.7%) |
| June 2012 | - | $1800.00(-35.7%) |
| June 2012 | $1800.00(-68.4%) | - |
| Mar 2012 | - | $2800.00(+250.0%) |
| Dec 2011 | - | $800.00(-88.2%) |
| Sept 2011 | - | $6800.00(+19.3%) |
| June 2011 | $5700.00(-87.2%) | $5700.00(-67.4%) |
| Mar 2011 | - | $17.50 K(-18.2%) |
| Dec 2010 | - | $21.40 K(-52.0%) |
| June 2010 | $44.60 K | $44.60 K |
FAQ
- What is Kintara Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Kintara Therapeutics?
- What is Kintara Therapeutics annual cash & cash equivalents year-on-year change?
- What is Kintara Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Kintara Therapeutics?
- What is Kintara Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Kintara Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of KTRA is $4.91 M
What is the all time high annual cash & cash equivalents for Kintara Therapeutics?
Kintara Therapeutics all-time high annual cash & cash equivalents is $11.78 M
What is Kintara Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, KTRA annual cash & cash equivalents has changed by +$3.37 M (+219.80%)
What is Kintara Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of KTRA is $4.91 M
What is the all time high quarterly cash and cash equivalents for Kintara Therapeutics?
Kintara Therapeutics all-time high quarterly cash and cash equivalents is $22.60 M
What is Kintara Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, KTRA quarterly cash and cash equivalents has changed by +$4.69 M (+2172.69%)